Page last updated: 2024-10-26

diclofenac and Cholangitis

diclofenac has been researched along with Cholangitis in 1 studies

Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.

Cholangitis: Inflammation of the biliary ductal system (BILE DUCTS); intrahepatic, extrahepatic, or both.

Research Excerpts

ExcerptRelevanceReference
"We aimed to investigate the preventive effect of oral diclofenac on pancreatitis after ERCP in a multicenter, randomized, prospective, placebo-controlled, double-blind trial."9.22No Benefit of Oral Diclofenac on Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis. ( Doi, S; Hayashi, T; Hisai, H; Ishiwatari, H; Iwashita, T; Kato, J; Kawakami, H; Kawakubo, K; Matsusaki, S; Ono, M; Sakamoto, N; Sonoda, T; Urata, T; Yasuda, I, 2016)
"We aimed to investigate the preventive effect of oral diclofenac on pancreatitis after ERCP in a multicenter, randomized, prospective, placebo-controlled, double-blind trial."5.22No Benefit of Oral Diclofenac on Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis. ( Doi, S; Hayashi, T; Hisai, H; Ishiwatari, H; Iwashita, T; Kato, J; Kawakami, H; Kawakubo, K; Matsusaki, S; Ono, M; Sakamoto, N; Sonoda, T; Urata, T; Yasuda, I, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishiwatari, H1
Urata, T1
Yasuda, I1
Matsusaki, S1
Hisai, H1
Kawakami, H1
Ono, M1
Iwashita, T1
Doi, S1
Kawakubo, K1
Hayashi, T1
Sonoda, T1
Sakamoto, N1
Kato, J1

Trials

1 trial available for diclofenac and Cholangitis

ArticleYear
No Benefit of Oral Diclofenac on Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.
    Digestive diseases and sciences, 2016, Volume: 61, Issue:11

    Topics: Administration, Oral; Aged; Aged, 80 and over; Amylases; Anti-Inflammatory Agents, Non-Steroidal; Au

2016